What every beginner should know

'Research Use Only' (RUO) is a labeling category vendors use to sell peptides as laboratory chemicals rather than human-grade drugs. It defines who the vendor is selling to and what the product is officially intended for. RUO products are not approved for human consumption by any regulatory authority — that approval is what FDA-approved drugs have, and what compounded prescriptions have under physician oversight.

Practically, RUO is the vendor's legal shield. By labeling a product 'for research only,' the vendor avoids the regulatory framework that governs human drugs (manufacturing standards, clinical trials, prescription requirements, marketing rules). The trade-off is that the vendor cannot make any therapeutic claims and cannot legally direct end-use.

What this means for you: RUO does not mean unsafe. It also does not mean safe. It means untested in the human-drug regulatory framework. You are taking on the role of researcher and assuming the responsibilities that come with that — including evaluating the supplier's quality systems, reading the certificate of analysis, and making informed choices about whether and how to use what you've purchased.

The strongest signal of a serious RUO supplier is rigorous COA testing. See the COA Education page for what each test actually measures.

Peptide contamination has three main sources: bacterial endotoxins, viable microorganisms, and elemental impurities. Each is a different problem, requires a different test, and has a different consequence.

Bacterial endotoxins are the toxic outer-wall components of Gram-negative bacteria. They are released when bacterial cells break apart, and they can persist long after the organisms themselves are gone. Standard sterile filtration (0.22 micrometer) removes intact bacteria but does not remove endotoxin molecules. A vial can show 'no growth' on a sterility test and still carry significant endotoxin load. Endotoxins trigger immune responses ranging from mild fevers to serious systemic inflammation, even at low concentrations.

Viable microorganisms — bacteria, yeasts, molds — are caught by sterility testing. The test inoculates a sample into growth media and watches for growth over a defined incubation window. A pass means the tested portion did not show growth. Sterility testing samples a portion of a batch, not every vial, so a single COA cannot guarantee every unit in the lot is sterile.

Elemental impurities are heavy metals (lead, arsenic, cadmium, mercury, sometimes catalyst residues like palladium) introduced during synthesis through reagents, equipment, or raw materials. ICP-MS testing measures these at parts-per-billion. A peptide can pass microbial tests yet fail elemental limits if the synthesis chemistry was sloppy.

All three matter and all three are tested separately. A complete COA addresses all three.

Quality indicators come in two layers: what you can verify yourself by looking at the vial, and what you have to read on the certificate of analysis.

Visual checks. A properly lyophilized peptide vial contains a fluffy white powder that may look like a thin disc, a small puck, or a fine layer at the bottom of the vial. Discoloration (yellow tint, brown spots, anything pink), visible particles, or a vial that arrives already partially dissolved or oily are red flags. Powder that has 'run' down the side of the vial indicates the lyophilization cycle was inadequate or the vial was exposed to moisture during shipping.

Reconstituted peptide should be clear after gentle swirling. Persistent cloudiness, particulate matter, or visible debris means stop. A properly stored, freshly reconstituted vial should not smell like anything noticeable.

COA red flags: missing lot number, missing test method, missing acceptance criteria, results without units, claims of 99%+ purity without method specified (HPLC vs MS vs other), 'conforms' without details, and most damningly, a COA dated months or years before the vial you received was filled. Reputable vendors test by lot and reference the lot number both on the vial label and on the COA.

Lab credibility matters. ISO 17025 accreditation is the standard for analytical laboratories. Labs that publish COAs through a verification portal (where you can look up the lot number directly) add a meaningful layer of trust above PDFs that could be edited.

Lyophilized (powder) peptides are stable for 18-24 months in a freezer (-20°C), 6-12 months in a refrigerator, and degrade meaningfully at room temperature over weeks. Repeated freeze-thaw cycles damage peptide structure — choose one freezer position and leave it there until ready to reconstitute.

Reconstituted peptides are a different category and degrade much faster. General stability windows in the fridge: BPC-157 around 7-14 days, GHK-Cu around 30 days (use glass; copper binds plastic), Ipamorelin / CJC-1295 (no DAC) around 14-30 days, TB-500 around 30-60 days, GLP-class drugs (semaglutide, tirzepatide, retatrutide) 30-60 days. Always check the vendor data sheet.

Never freeze a reconstituted vial. Freezing and thawing reconstituted peptide damages structure and can cause precipitation that doesn't redissolve cleanly.

Temperature shock matters. Bringing a vial straight from the freezer to room-temperature handling causes condensation inside the vial that will degrade the peptide once reconstituted. Move from freezer to fridge for at least an hour before reconstitution.

Travel: a small insulated bag with a fridge gel pack handles 24-48 hours of transit for most peptides. The GLP class is more forgiving — sub-24 hours at room temperature is generally fine. For everything else, keep cold.

Light: ambers vials are standard because UV degrades many peptides. If you receive a clear-glass vial, store it in the dark.

Regulation matters because the same compound can be a prescription drug in one country, a research-only chemical in another, and effectively illegal to import in a third. Pepdex covers documented protocols, but compliance is your responsibility.

United States. Compounds fall into FDA-approved drugs (semaglutide, tirzepatide, MT-1/Scenesse, PT-141/Vyleesi, tesamorelin/Egrifta, HGH, teriparatide), FDA Bulks-list compounding categories (per the February 2026 reclassification, BPC-157, TB-500, CJC-1295, Ipamorelin, AOD-9604, GHK-Cu, Thymosin Alpha-1, Selank, Semax, KPV, MOTS-C are moving back to Category 1 — legal for compounding pharmacies under physician prescription), Research-Use-Only chemicals (most others), and DEA-scheduled substances (HGH for non-medical use is restricted under the Anabolic Steroid Control Act).

European Union. Some peptides have EMA approval (semaglutide, tirzepatide, Scenesse). Others sit in regulatory gray zones, and several Russian-origin peptides (Selank, Semax, Cortexin) are licensed prescription drugs in some EU countries while remaining unapproved in others.

United Kingdom. Post-Brexit regulation broadly tracks EU but with the MHRA acting independently. Importing research peptides for personal use carries customs risk that varies by current enforcement priorities.

Australia. Strict TGA regulation of personal importation. Schedule 4 prescription requirements apply to many peptides; importation without prescription has been actively enforced.

Canada. Health Canada classifies most research peptides as unapproved drugs. Personal importation is technically restricted; enforcement varies.

Tested-athlete considerations. WADA's Prohibited List applies regardless of national regulation. Most performance peptides are S2-banned. BPC-157 is on the S0 (Non-Approved Substances) list. Always check the current WADA list before competition.